Lazard Asset Management LLC reduces its holding of China National Pharmaceutical Group Corporation (01099) by 546,400 shares at an average price of HK$18.48 per share.

According to the Zhitong Finance and Economics APP, the latest information from the Hong Kong Stock Exchange shows that on September 24, Lazard Asset Management LLC reduced its holdings of China National Pharmaceutical Group Corporation (01099) by 546,400 shares, with an average price of HK$18.48 per share, for a total amount of approximately HK$100.975 million. After the reduction, the latest number of shares held is approximately 134 million, and the latest shareholding ratio is 9.99%.